HALOZYME REPORTS SECOND QUARTER 2024 FINANCIAL AND OPERATING RESULTS

Go back to HALOZYME REPORTS SECOND QUARTER 2024 FINANCIAL AND OPERATING RESULTS
Halozyme Therapeutics, Inc. (NASDAQ: HALO) Delayed: 85.76 --0 (-0%)
Previous Close $85.76    52 Week High $18.39 
Open $85.76    52 Week Low $6.96 
Day High $85.76    P/E N/A 
Day Low $85.76    EPS $-0.58 
Volume 38,108